Clinical trial
A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)
NCT00351533 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00351533 |
|---|---|
| Title | A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI) |
| Official title | A Randomized, Double-blind Study of the Effect of Fish Oil (Eicosapentaenoic Acid and Docosahexanoic Acid) on Lung and Systemic Inflammation in Patients With Acute Lung Injury (ALI) |
| Lead sponsor | University of Washington, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH American Thoracic Society Acute Respiratory Distress Syndrome Foundation American Society for Parenteral and Enteral Nutrition |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Respiratory Distress Syndrome, Adult, Acute Lung Injury, Acute Respiratory Distress Syndrome |
| Intervention type | Drug |
| Interventions | Fish oil (eicosapentaenoic acid and docosahexanoic acid) |
| Enrollment | 90 |
| Start date | Jul 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Jul 13, 2006 |
| Last update posted | Oct 3, 2011 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: